Drug intelligence / Profile preview

magnesium pidolate

Development stage
Unknown
Lead developer
Faes Farma
Modality
Small Molecules
Administration
Oral
01

Overview

Actimag is an oral solution containing magnesium pidolate, a highly bioavailable organic salt of magnesium. It is indicated for the prevention and treatment of magnesium deficiency (hypomagnesemia) in adults and adolescents. Magnesium is an essential mineral that serves as a cofactor for over 300 enzymatic reactions in the body, playing a critical role in energy metabolism, protein synthesis, muscle contraction, and neurochemical transmission. At the cellular level, magnesium acts as a physiological calcium antagonist, modulating voltage-gated calcium channels and blocking N-methyl-D-aspartate (NMDA) glutamate receptors to regulate neuronal excitability. Actimag is developed and marketed by Faes Farma.

Brand names
ActimagMag 2Mag2Mag-2MaginjectableMagnesonaSolumag
Other names
magnesium L-pidolatemagnesium pyroglutamatepidolate de magnésiumpidolato de magnesiopidolato magnésico
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on magnesium pidolate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium pidolate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call